No Data
No Data
Apellis Pharmaceuticals Price Target Cut to $86.00/Share From $100.00 by Baird
Apellis Pharmaceuticals Is Maintained at Outperform by Baird
Express News | Apellis Pharmaceuticals Inc : Baird Cuts Target Price to $86 From $100
Stuart Therapeutics, Inc. Announces Key Addition to Its Executive Team
Express News | Baird Maintains Outperform on Apellis Pharmaceuticals, Maintains $100 Price Target
Baird Initiates Apellis Pharmaceuticals(APLS.US) With Buy Rating, Announces Target Price $100
No Data
EZ_money OP : this is worth way more than the price